IMI - Clinical Myopia Management Guidelines report

Kate Gifford, Kathryn Richdale, Pauline Kang, Thomas Aller, Carly Lam, Y Maria Liu, Langis Michaud, Jeroen Mulder, Janis Orr, Kathryn Rose, Kathryn J Saunders, Dirk Seidel, Willem Tideman, Padmaja Sankaridurg

Research output: Contribution to journalArticle

Abstract

Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.
LanguageEnglish
JournalInvestigative Ophthalmology and Visual Science
Publication statusPublished - Feb 2019

Fingerprint

Myopia
Guidelines
Practice Guidelines
Off-Label Use
Therapeutics
Professional Education
Evidence-Based Practice
Practice Management
Continuing Education
Informed Consent
Caregivers
Epidemiology
Language
Communication
Pharmacology

Keywords

  • Myopia control
  • myopia progression
  • clinical considerations
  • patient communication
  • practitioner education

Cite this

Gifford, K., Richdale, K., Kang, P., Aller, T., Lam, C., Liu, Y. M., ... Sankaridurg, P. (2019). IMI - Clinical Myopia Management Guidelines report. Investigative Ophthalmology and Visual Science.
Gifford, Kate ; Richdale, Kathryn ; Kang, Pauline ; Aller, Thomas ; Lam, Carly ; Liu, Y Maria ; Michaud, Langis ; Mulder, Jeroen ; Orr, Janis ; Rose, Kathryn ; Saunders, Kathryn J ; Seidel, Dirk ; Tideman, Willem ; Sankaridurg, Padmaja. / IMI - Clinical Myopia Management Guidelines report. In: Investigative Ophthalmology and Visual Science. 2019.
@article{010910c28677436480021f74da4c9f82,
title = "IMI - Clinical Myopia Management Guidelines report",
abstract = "Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.",
keywords = "Myopia control, myopia progression, clinical considerations, patient communication, practitioner education",
author = "Kate Gifford and Kathryn Richdale and Pauline Kang and Thomas Aller and Carly Lam and Liu, {Y Maria} and Langis Michaud and Jeroen Mulder and Janis Orr and Kathryn Rose and Saunders, {Kathryn J} and Dirk Seidel and Willem Tideman and Padmaja Sankaridurg",
year = "2019",
month = "2",
language = "English",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",

}

Gifford, K, Richdale, K, Kang, P, Aller, T, Lam, C, Liu, YM, Michaud, L, Mulder, J, Orr, J, Rose, K, Saunders, KJ, Seidel, D, Tideman, W & Sankaridurg, P 2019, 'IMI - Clinical Myopia Management Guidelines report', Investigative Ophthalmology and Visual Science.

IMI - Clinical Myopia Management Guidelines report. / Gifford, Kate; Richdale, Kathryn; Kang, Pauline; Aller, Thomas; Lam, Carly; Liu, Y Maria; Michaud, Langis; Mulder, Jeroen; Orr, Janis; Rose, Kathryn; Saunders, Kathryn J; Seidel, Dirk; Tideman, Willem; Sankaridurg, Padmaja.

In: Investigative Ophthalmology and Visual Science, 02.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - IMI - Clinical Myopia Management Guidelines report

AU - Gifford, Kate

AU - Richdale, Kathryn

AU - Kang, Pauline

AU - Aller, Thomas

AU - Lam, Carly

AU - Liu, Y Maria

AU - Michaud, Langis

AU - Mulder, Jeroen

AU - Orr, Janis

AU - Rose, Kathryn

AU - Saunders, Kathryn J

AU - Seidel, Dirk

AU - Tideman, Willem

AU - Sankaridurg, Padmaja

PY - 2019/2

Y1 - 2019/2

N2 - Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.

AB - Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.

KW - Myopia control

KW - myopia progression

KW - clinical considerations

KW - patient communication

KW - practitioner education

M3 - Article

JO - Investigative Ophthalmology and Visual Science

T2 - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

ER -

Gifford K, Richdale K, Kang P, Aller T, Lam C, Liu YM et al. IMI - Clinical Myopia Management Guidelines report. Investigative Ophthalmology and Visual Science. 2019 Feb.